Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Let's talk about something that's been flying under the radar but shouldn't be - Router Protocol’s $ROUTE. While everyone's been busy chasing the latest meme coins ...

Emcor Group (EME) closed the latest trading day at $531.65, indicating a -0.03% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.29%.

Lupin Receives Approval from U. S. FDA for Ipratropium Bromide Nasal Solution (NASAL Spray) 0.03% Lupin and Natco Receive Approval from U. S. FDA for Bosentan Tablets for Oral Suspension. Intimation ...

Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...